These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13875353)

  • 1. Intracellular distribution of 5-bis(2-chloroethyl) aminouracil-2-C-14 in tissues of tumor-bearing rats.
    BYVOET P; BUSCH H
    Cancer Res; 1962 Feb; 22():249-53. PubMed ID: 13875353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on the antimitotic properties of antagonists of natural pyrimidine bases. II. 6-Azauracil, 6-azathymine, 2-thio-5-methylcytosine and 4-methyl-5-bis(beta-chloroethyl)-aminouracil].
    TRUHAUT R; DEYSSON G
    Bull Soc Chim Biol (Paris); 1962; 44():525-35. PubMed ID: 13922681
    [No Abstract]   [Full Text] [Related]  

  • 3. The antitumor activity of 5-bis-2'-chlorethyl)-aminouracil (uracil mustard).
    LANE M; KELLY MG
    Cancer Res; 1960 May; 20():511-7. PubMed ID: 14413839
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Bis(2-chloroethyl)aminouracil, a new antitumor agent.
    LYTTLE DA; PETERING HG
    J Natl Cancer Inst; 1959 Jul; 23():153-62. PubMed ID: 14419216
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of uptake of L-arginine-U-14C into chromatographically separated cationic nuclear proteins of tissues of tumour-bearing rats by 5-bis (2-chloroethyl) aminouracil.
    HONIG GR; DAVIS JR; BUSCH H
    Biochem Pharmacol; 1961 Jun; 6():233-40. PubMed ID: 13715665
    [No Abstract]   [Full Text] [Related]  

  • 6. b-Bis (chloroethyl) aminouracil, a new antitumor agent.
    LYTTLE DA; PETERING HG
    J Natl Cancer Inst; 1959 Jul; 23(1):153-62. PubMed ID: 13673275
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of uptake of Larginine-U-C14 into nuclear proteins by 5-bis (2-chloroethyl) aminouracil.
    BUSCH H; AMER SM; NYHAN WL
    J Pharmacol Exp Ther; 1959 Nov; 127():195-9. PubMed ID: 13806373
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of uptake of L-lysine-U-C-14 into chromatographic fractions of cationic nuclear proteins by 5-bis-(2'-chloroethyl)-aminouracil.
    DAVIS JR; HONIG GR; BUSCH H
    Tex Rep Biol Med; 1961; 19():761-8. PubMed ID: 13883928
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of 5-bis(2-chiorethyl)aminouracil on the blood and normal hemolymphopoietic tissues].
    SCALTRINI GC; CONIGLIARO S
    Tumori; 1961; 47():245-60. PubMed ID: 13747037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineoplastic effect of 4-methyl-5-di-(chloroethyl)-amino-uracil (dopane)].
    LARIONOV LF; PLATONOVA GN
    Vopr Onkol; 1955; 1(5):36-8. PubMed ID: 13299840
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopan and related compounds.
    LARIONOV L
    Cancer Chemother Rep; 1961 Jun; 12():205-6. PubMed ID: 13759106
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical changes during treatment with 5-fluorouracil.
    REICHARD P
    Cancer Chemother Rep; 1962 Feb; 16():347-52. PubMed ID: 14491142
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopan.
    WHITE FR
    Cancer Chemother Rep; 1961 Oct; 14():169-73. PubMed ID: 14006515
    [No Abstract]   [Full Text] [Related]  

  • 14. [EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
    CHANG M
    Nihon Yakurigaku Zasshi; 1964 Sep; 60():413-34. PubMed ID: 14271233
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
    Bjerkvig R; Oredsson SM; Marton LJ; Linden M; Deen DF
    Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 5-fluorouracil by combination chemotherapy in animals.
    WOLBERG WH; CURRERI AR
    Cancer Chemother Rep; 1960 Feb; 6():6-7. PubMed ID: 13845611
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical study of 5-fluorouracil.
    GOLD GL; HALL TC; SHNIDER BJ; SELAWRY O; COLSKY J; OWENS AH; DEDERICK MM; HOLLAND JF; BRINDLEY CO; JONES R
    Cancer Res; 1959 Oct; 19():935-9. PubMed ID: 13850554
    [No Abstract]   [Full Text] [Related]  

  • 18. A synopsis of recent investigations of 6-azauridine (NSC-32074).
    WELCH AD; HANDSCHUMACHER RE; FINCH SC; JAFFE JJ; CARDOSO SS; CALABRESI P
    Cancer Chemother Rep; 1960 Nov; 9():39-46. PubMed ID: 13784172
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Fluorouracil and its ribosides.
    WHITE FR
    Cancer Chemother Rep; 1960 Feb; 6():94-114. PubMed ID: 13844347
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
    Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC
    J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.